(Q44338515)

2 December 2017

title

Spontaneous reversion from blast to chronic phase after withdrawal of imatinib mesylate in a patient with chronic myelogenous leukemia (English)

1 reference

2 December 2017

1 reference

Nina Shih Liu

1

1 reference

2 December 2017

Susan O'Brien

series ordinal

2

1 reference

2 December 2017

publication date

1 December 2002

1 reference

2 December 2017

1 reference

2 December 2017

volume

43

1 reference

2 December 2017

issue

12

1 reference

2 December 2017

page(s)

2413-2415

1 reference

Chronic myelogenous leukemia: biology and therapy

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Imatinib mesylate--a new oral targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040152

10.1080/1042819021000040152

21 January 2018

Identifiers

DOI

1 reference

release_2nctmm4ggreu5pl2uv2ttdcnve

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2nctmm4ggreu5pl2uv2ttdcnve

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference